Signal Transduction and Targeted Therapy

Signal Transduction and Targeted Therapy

Discipline	Biomedicine Pharmacology
Language	English
Edited  by	Carlo M. Croce Kang Zhang Yu-Quan Wei
Publication details
History	2016–present
Publisher	Nature Research
Frequency	Continuous
Open access	Yes
Impact factor	40.8 (2023)
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt )
ISO 4	Signal Transduct. Target. Ther.
Indexing CODEN (alt  · alt2) · JSTOR (alt) · LCCN (alt) MIAR  · NLM (alt) · Scopus  · W&L
ISSN	2095-9907  (print) 2059-3635  (web)
LCCN	2016243461
OCLC  no.	1026877558
Links
Journal homepage Online archive

Signal Transduction and Targeted Therapy is a multidisciplinary peer-reviewed open access scientific journal covering biomedical research with a particular focus on signal transduction and its application to the drug development process. It was established in 2016 and is published by Nature Research. The editors-in-chief are Carlo M. Croce (Ohio State University), Kang Zhang (Macau University of Science and Technology), and Yu-Quan Wei (West China Medical Center). According to the Journal Citation Reports , the journal has a 2023 impact factor of 40.8. ^[1]

Abstract & Indexing

• Science Citation Index Expanded
• BIOSIS
• Open Access Journals (DOAJ) ^[2]
• MEDLINE ^[3]
• PubMed Central (PMC)
• Scopus

Sponsoring

The Journal is sponsored by West China Medical Center. ^[4]

References

1. "Signal Transduction and Targeted Therapy". 2023 Journal Citation Reports . Web of Science (Science ed.). Clarivate Analytics. 2023.
2. IndexHub. "DOAJ Indexed Journals". IndexHub. Retrieved 22 December 2024.
3. Medline. "Journals Recently Accepted for Inclusion in MEDLINE". MEDLINE. Retrieved 22 December 2024.
4. Signal Transduction and Targeted Therapy - About the Partner